Stock screener

TARA

Conviction 9HealthcareScan · Fri, Oct 2, 2026

Protara Therapeutics, Inc. (TARA) closed at $2.70 (-2.17%) on Oct 2, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 19, RS Rating 16, -64.3% from its 52-week high, -49.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

TARA$2.70-2.17%
ResistanceSupportVol 14
63 bars
Vol MA14 2.13M
Jul 7Jul 23Aug 11Aug 27Sep 16Oct 2
Protara Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.protaratx.com ↗
Price2.70
Change-2.17%
Gap+9.60%
Rel volume1.43×
Avg volume1.64M
Avg $ vol5.35M
SMA 203.51
SMA 503.78
SMA 2004.85
Price vs 50-28.50%
Price vs 200-44.31%
MA stackbearish
50/200 cross—
Supertrenddown · 3.56
RSI (14)19
MACD hist-0.09
MACD cross—
Stoch %K / %D6 / 5
ADX (14)28
+DI / −DI8 / 34
RSI divergenceBullish
MACD divergenceBullish
ATR %8.37%
ADR %6.43%
52w high7.56
52w low2.70
From 52w high-64.29%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width40.89%
%B-0.06
Donchian pos5.40%
Donchian high4.02
Donchian low2.63
AVWAP (52w high)4.98
vs AVWAP high-45.81%
AVWAP (52w low)2.78
vs AVWAP low-2.99%
OBV trendDown
Chaikin MF (20)-0.55
Today vs 20d1.43×
Avg vol (14d)2.15M
Avg vol (20d)1.64M
Avg $ vol (20d)5.35M
Market cap159.56M
RS Rating16 / 99
RS 3m (vs SPY)-36.27%
RS 6m (vs SPY)-64.52%
RS line new highNo
Trend template0/8
Technical rank8.2
1 week-17.68%
1 month-31.47%
3 months-33.82%
6 months-47.16%
1 year-38.78%
YTD-49.81%
P/E-2.78
P/B0.99
P/S54.12
P/FCF-2.83
EPS-1.34
Div yield—
ROE-35.61%
ROA-32.62%
Debt/Eq0.00
Current10.97
EV/EBITDA-2.21
Gross margin—
Net margin—
Rev growth0.00%
EPS growth-28.80%
Price target24.00
Target upside788.89%
Analyst ratingBuy
Institutional90.83%
Ent. value142.48M
Revenue2.95M
Net income-21.67M
Gross profit—
Free cash flow-56.46M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out56.2M
Employees51
ListedFri, Jan 10, 2020
Free float45.86M
Float %88.8%
Short interest4.43M
Days to cover12.4d
Short volume19.1%
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.36 vs −$0.33
Last surprise-9.1% miss
Setup gradeD
Conviction9 / 100
Pattern quality—
Tech rank8.2 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.08
Support3.58
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TARA

All disclosures →
No recent disclosed trades by Congress in TARA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TARA

InsiderSideShares
BESHAR LUKE M
Director · Stock Option (Right to Buy) · 2026-06-15
Grant31K

SEC filings

EDGAR filings in TARA · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.